Clinical trial
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00403715 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00403715 |
|---|---|
| Title | Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease |
| Official title | A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of Multiple Ocular Instillations of INS365 Ophthalmic Solution vs. Placebo in Subjects With Dry Eye Disease |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dry Eye Disease |
| Intervention type | Drug |
| Interventions | diquafosol tetrasodium (INS365) Ophthalmic Solution |
| Enrollment | 500 |
| Start date | Feb 1, 2001 |
| Primary completion | Sep 1, 2002 |
| Completion | Sep 1, 2002 |
| First posted | Nov 27, 2006 |
| Last update posted | Nov 29, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: